Stratview Research has published a new report on the Nicotine Replacement Therapy Products Market, segmented by Type (Sprays, Inhalers, Chewing gums, Transdermal patches, Lozenges, Sublingual tablets), Application (Home, Hospital), and Region - COVID-19 Impact Analysis and Forecast to 2026.

Market Dynamics

The growth of the global nicotine replacement therapy (NRT) products market is primarily driven by increasing awareness among consumers about the ill effects of smoking. The rising number of smokers across geographies is likely to drive the growth of nicotine replacement therapy (NRT) products at a significant rate during the review period. In addition to this, increasing government initiatives aimed at creating awareness about the adverse impact of smoking on health is likely to create lucrative opportunities for the players operating in the global market in the coming years.

 Get a free sample report here: https://www.stratviewresearch.com/Request-Sample/2300/Nicotine-Replacement-Therapy-(NRT)-Products-Market.html#form

Key Players

The following are some of the key players in the Nicotine Replacement Therapy Products Market:

  • Pfizer Inc. (US)
  • Cipla Limited (India)
  • Novartis International AG (Switzerland)
  • GlaxoSmithKline plc (UK)
  • The Takeda Pharmaceutical Company Limited (Japan)
  • McNeil (US)
  • Revolymer (UK)
  • Imperial Brands plc (UK)
  • VMR Products (India).

COVID-19 Impact on Global Nicotine Replacement Therapy Products Market

The outbreak of the COVID-19 virus has affected the growth of the Nicotine Replacement Therapy Products market significantly. Stringent lockdown measures and restricted movement of people affected the production and product supply for a short period and thus, affected the market growth.

Nicotine Replacement Therapy Products Market Segmentation:

By type, the nicotine replacement therapy (NRT) products market has been bifurcated into homes and hospitals. Under these, the home segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment growth can be attributed to the increasing consumption of nicotine replacement therapy products across households.

By region, the market in Asia-Pacific accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The segment growth is primarily attributed to the presence of a large number of smokers coupled with the presence of various tobacco manufacturers. The market growth in the North American region is expected to be driven by the increasing prevalence of smoking-related health disorders.

For inquiries, Contact:

Ritesh Gandecha

Stratview Research

E-mail: [email protected]

Direct: +1-313-307-4176

About Stratview Research
Stratview Research is a global market intelligence firm helping its clients’ tract the ever-evolving market scenarios through customised and syndicated reports. The reports offered here are gathered with the help of our wide-ranging and reliable secondary sources and in-depth interviews with the linchpins within the market. Extrapolated through primary and secondary research, Stratview Research’s reports help you remain ahead of the curve by enabling you to understand the current market trends and challenges coming on your way. Our strong team of industry veterans and researchers assure high quality research and strategic insights that help companies worldwide in effective decision making.